Опыт применения нестероидных антиандрогенов в лечении местно-распространенного и метастатического рака предстательной железы
2007
The paper presents the results of treatment of 57 patients with locally advanced and metastatic prostatic carcinoma (PC) (T3Р4N0M0, T1Р4N1M0, T1Р4N0M1, and T1Р4N1M1) (mean age 64.2±7.1 years) with Russian nonsteroidal antiandrogen Bilumide® at a dose of 50 mg/day for the maximum androgenic block after bilateral orchiectomy. The efficacy and safety of the drug were evaluated by the IPSS and QoL scales, laboratory and ultrasound studies, as well as osteoscintigraphy and uroflowmetry. The open-labeled non-comparative studies indicated the clinical effectiveness and safety of Bilumide that can be recommended for the treatment of locally advanced and metastatic PC. Further studies to compare Bilumide® with other antiandrogens commonly used in practice are required
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI